CPN-351 (TFA)
CPN-351 TFA (compound 9a), a pentapeptide, is a selective antagonist of human NMUR1 with a pA2 of 7.35. The antagonistic effect of CPN-351 TFA on human NMUR1 is 10 times higher than that on NMUR2. CPN-351 TFA can be used in the study of inflammation[1]. X
Product Specifications
UNSPSC
12352209
Target
Neuromedin U Receptor (NMUR)
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.06
Smiles
CN([C@H](C(N[C@@](CC1=CC=CC=C1)(C(N[C@H](C(N2CCC[C@H]2C(N[C@H](C(N)=O)CCCNC(N)=N)=O)=O)CCCNC(N)=N)=O)C)=O)CC3=CNC4=C3C=CC=C4)C(CC5=CC=CS5)=O.OC(C(F)(F)F)=O.
Molecular Formula
C45H61N13O6S.xC2HF3O2
Molecular Weight
912.11 (free base)
References & Citations
[1]Takayama K, et al. Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1. ACS Med Chem Lett. 2024 May 24;15 (6) :885-891.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
NMUR1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
